| Dr Victoria Tewfik Elias Rizk, MD | |
|
136 Mountainview Blvd, Basking Ridge, NJ 07920-3444 | |
| (908) 542-3379 | |
| Not Available |
| Full Name | Dr Victoria Tewfik Elias Rizk |
|---|---|
| Gender | Female |
| Speciality | Medical Oncology |
| Experience | 11 Years |
| Location | 136 Mountainview Blvd, Basking Ridge, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518200195 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 25MA10693300 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tampa General Hospital | Tampa, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cancer Center Of South Florida Pllc | 8426120239 | 28 |
| Tampa General Medical Group Inc | 7416253828 | 227 |
News Archive
A tool with the potential to determine the level of tissue damage in patients with osteo-arthritis, sports injuries and other conditions affecting bone and cartilage is being developed by QUT researchers. Professor Oloyede said that the device, which he calls a "smarthroscope", may be able to reduce the cost of surgery, eliminate unnecessary surgery, and could be useful in developing countries.
There are only two FDA/EMEA approved drugs currently available for treating advanced melanoma. The available drugs, however, are not completely effective and have adverse effects. Unmet needs of patients, especially those with advanced melanoma are therefore quite high and have led to a low drug adoption and market growth over the years. The future looks brighter though, with a few promising drugs in pipeline for advanced melanoma.
There exists a "type" of cancer that is common yet rarely discussed—metastatic cancer, or cancer that has spread from the part of the body where it originated (the primary tumor) to another (such as lungs, bones or liver). Although much research is being done to combat primary tumors, there still exists a crucial need to find a treatment that can be effective against metastatic cancer, or "mets." Could a virus be the answer that finally beats the mets?
Endoscopy patients will soon be able to ‘play' with their insides as part of an innovative research project that aims to integrate humans and technology through fun experiences with ingestible sensors.
› Verified 8 days ago
| Entity Name | Cancer Center Of South Florida Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194990333 PECOS PAC ID: 8426120239 Enrollment ID: O20080710000224 |
News Archive
A tool with the potential to determine the level of tissue damage in patients with osteo-arthritis, sports injuries and other conditions affecting bone and cartilage is being developed by QUT researchers. Professor Oloyede said that the device, which he calls a "smarthroscope", may be able to reduce the cost of surgery, eliminate unnecessary surgery, and could be useful in developing countries.
There are only two FDA/EMEA approved drugs currently available for treating advanced melanoma. The available drugs, however, are not completely effective and have adverse effects. Unmet needs of patients, especially those with advanced melanoma are therefore quite high and have led to a low drug adoption and market growth over the years. The future looks brighter though, with a few promising drugs in pipeline for advanced melanoma.
There exists a "type" of cancer that is common yet rarely discussed—metastatic cancer, or cancer that has spread from the part of the body where it originated (the primary tumor) to another (such as lungs, bones or liver). Although much research is being done to combat primary tumors, there still exists a crucial need to find a treatment that can be effective against metastatic cancer, or "mets." Could a virus be the answer that finally beats the mets?
Endoscopy patients will soon be able to ‘play' with their insides as part of an innovative research project that aims to integrate humans and technology through fun experiences with ingestible sensors.
› Verified 8 days ago
| Entity Name | Tampa General Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043557853 PECOS PAC ID: 7416253828 Enrollment ID: O20160310002525 |
News Archive
A tool with the potential to determine the level of tissue damage in patients with osteo-arthritis, sports injuries and other conditions affecting bone and cartilage is being developed by QUT researchers. Professor Oloyede said that the device, which he calls a "smarthroscope", may be able to reduce the cost of surgery, eliminate unnecessary surgery, and could be useful in developing countries.
There are only two FDA/EMEA approved drugs currently available for treating advanced melanoma. The available drugs, however, are not completely effective and have adverse effects. Unmet needs of patients, especially those with advanced melanoma are therefore quite high and have led to a low drug adoption and market growth over the years. The future looks brighter though, with a few promising drugs in pipeline for advanced melanoma.
There exists a "type" of cancer that is common yet rarely discussed—metastatic cancer, or cancer that has spread from the part of the body where it originated (the primary tumor) to another (such as lungs, bones or liver). Although much research is being done to combat primary tumors, there still exists a crucial need to find a treatment that can be effective against metastatic cancer, or "mets." Could a virus be the answer that finally beats the mets?
Endoscopy patients will soon be able to ‘play' with their insides as part of an innovative research project that aims to integrate humans and technology through fun experiences with ingestible sensors.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Victoria Tewfik Elias Rizk, MD 136 Mountainview Blvd, Basking Ridge, NJ 07920-3444 Ph: () - | Dr Victoria Tewfik Elias Rizk, MD 136 Mountainview Blvd, Basking Ridge, NJ 07920-3444 Ph: (908) 542-3379 |
News Archive
A tool with the potential to determine the level of tissue damage in patients with osteo-arthritis, sports injuries and other conditions affecting bone and cartilage is being developed by QUT researchers. Professor Oloyede said that the device, which he calls a "smarthroscope", may be able to reduce the cost of surgery, eliminate unnecessary surgery, and could be useful in developing countries.
There are only two FDA/EMEA approved drugs currently available for treating advanced melanoma. The available drugs, however, are not completely effective and have adverse effects. Unmet needs of patients, especially those with advanced melanoma are therefore quite high and have led to a low drug adoption and market growth over the years. The future looks brighter though, with a few promising drugs in pipeline for advanced melanoma.
There exists a "type" of cancer that is common yet rarely discussed—metastatic cancer, or cancer that has spread from the part of the body where it originated (the primary tumor) to another (such as lungs, bones or liver). Although much research is being done to combat primary tumors, there still exists a crucial need to find a treatment that can be effective against metastatic cancer, or "mets." Could a virus be the answer that finally beats the mets?
Endoscopy patients will soon be able to ‘play' with their insides as part of an innovative research project that aims to integrate humans and technology through fun experiences with ingestible sensors.
› Verified 8 days ago
Dr. Abraham Meltzer, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 62 Morgan Ln, Basking Ridge, NJ 07920 Phone: 908-326-6065 | |
Ephraim S Casper, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 136 Mountain View Blvd, Basking Ridge, NJ 07920 Phone: 908-542-3300 | |
Han Xiao, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 136 Mountain View Blvd, Basking Ridge, NJ 07920 Phone: 908-542-3300 | |
Dr. Melissa Georgette Mauro, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 233 Mount Airy Rd Ste 100, Basking Ridge, NJ 07920 Phone: 973-945-0790 Fax: 610-643-4523 | |
Dr. Joseph Sebastian Lutz, M.D. Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 211 S Finley Ave, Basking Ridge, NJ 07920 Phone: 908-766-0339 Fax: 908-204-9192 | |
Dr. Sree Bhavani Chalasani, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 136 Mountainview Blvd, Basking Ridge, NJ 07920 Phone: 908-542-3300 Fax: 908-542-3222 | |
Annemarie Fernandes Shepherd, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 136 Mountainview Blvd, Basking Ridge, NJ 07920 Phone: 908-542-3000 |